1.Geometric Calibration of Cone-beam CT System for Image Guided Proton Therapy.
Jin Sung KIM ; Min Kook CHO ; Young Bin CHO ; Han Bean YOUN ; Ho Kyung KIM ; Myounggeun YOON ; Dongho SHIN ; Sebyeung LEE ; Re Na LEE ; Sung Yong PARK ; Kwan Ho CHO
Korean Journal of Medical Physics 2008;19(4):209-218
According to improved radiation therapy technology such as IMRT and proton therapy, the accuracy of patient alignment system is more emphasized and IGRT is dominated research field in radiation oncology. We proposed to study the feasibility of cone-beam CT system using simple x-ray imaging systems for image guided proton therapy at National Cancer Center. 180 projection views (2,304x3,200, 14 bit with 127 micrometer pixel pitch) for the geometrical calibration phantom and humanoid phantoms (skull, abdomen) were acquired with 2degrees step angle using x-ray imaging system of proton therapy gantry room (360degrees for 1 rotation). The geometrical calibration was performed for misalignments between the x-ray source and the flat-panel detector, such as distances and slanted angle using available algorithm. With the geometrically calibrated projection view, Feldkamp cone-beam algorithm using Ram-Lak filter was implemented for CBCT reconstruction images for skull and abdomen phantom. The distance from x-ray source to the gantry isocenter, the distance from the flat panel to the isocenter were calculated as 1,517.5 mm, 591.12 mm and the rotated angle of flat panel detector around x-ray beam axis was considered as 0.25degrees. It was observed that the blurring artifacts, originated from the rotation of the detector, in the reconstructed toomographs were significantly reduced after the geometrical calibration. The demonstrated CBCT images for the skull and abdomen phantoms are very promising. We performed the geometrical calibration of the large gantry rotation system with simple x-ray imaging devices for CBCT reconstruction. The CBCT system for proton therapy will be used as a main patient alignment system for image guided proton therapy.
Abdomen
;
Artifacts
;
Axis, Cervical Vertebra
;
Calibration
;
Cone-Beam Computed Tomography
;
Humans
;
Isothiocyanates
;
Proton Therapy
;
Protons
;
Radiation Oncology
;
Skull
2.Clinical Features of Re-Emerging Hepatitis A: An Analysis of Patients Hospitalized during an Urban Epidemic in Korea.
Hee Kyoung CHOI ; Young Goo SONG ; Chang Oh KIM ; So Youn SHIN ; Bum Sik CHIN ; Sang Hoon HAN ; Sung Joon JIN ; Yun Tae CHAE ; Ji Hyeon BAEK ; Sun Bean KIM ; Do Young KIM ; Jun Yong PARK ; June Myung KIM ; Jun Yong CHOI
Yonsei Medical Journal 2011;52(4):686-691
From April 2008 to November 2008, many cases of hepatitis A were reported in Seoul and Gyeonggi Province in Korea. Furthermore, the rate of severe or fulminant hepatitis have significantly increased during the latest epidemic (13.4% vs. 5.2%, p=0.044). Therefore, widespread use of vaccine is warranted to reduce the burden of hepatitis A in Korea.
Adolescent
;
Adult
;
Child
;
Epidemics
;
Female
;
Hepatitis A/diagnosis/*epidemiology/prevention & control
;
Humans
;
Immunoenzyme Techniques
;
Male
;
Republic of Korea/epidemiology
;
Retrospective Studies
3.Interim Guidelines on Antiviral Therapy for COVID-19
Sun Bean KIM ; Kyungmin HUH ; Jung Yeon HEO ; Eun-Jeong JOO ; Youn Jeong KIM ; Won Suk CHOI ; Yae-Jean KIM ; Yu Bin SEO ; Young Kyung YOON ; Nam Su KU ; Su Jin JEONG ; Sung-Han KIM ; Kyong Ran PECK ; Joon Sup YEOM
Infection and Chemotherapy 2020;52(2):281-304
Since the first case was reported in Wuhan, Hubei Province, China on December 12, 2019, Coronavirus disease 2019 (COVID-19) has spread widely to other countries since January 2020. As of April 16, 2020, 10635 confirmed cases have been reported, with 230 deaths in Korea. COVID-19 patients may be asymptomatic or show various clinical manifestations, including acute symptoms such as fever, fatigue, sore throat; pneumonia presenting as acute respiratory distress syndrome; and multiple organ failure. As COVID-19 has such varied clinical manifestations and case fatality rates, no standard antiviral therapy regimen has been established other than supportive therapy. In the present guideline, we aim to introduce potentially helpful antiviral and other drug therapies based on in vivo and in vitro research and clinical experiences from many countries.